Copyright
©The Author(s) 2023.
World J Diabetes. Jun 15, 2023; 14(6): 808-819
Published online Jun 15, 2023. doi: 10.4239/wjd.v14.i6.808
Published online Jun 15, 2023. doi: 10.4239/wjd.v14.i6.808
Model | Species | Resveratrol consumption | Duration of treatment | Maternal outcomes | Offspring outcomes | Ref. |
C57BL/6 | Mice | 8.0 mg/kg | 16 gestation days | Inhibit expression levels of inflammatory factors, IL-1β, IL-6, CRP and TNF-α↓ | [24] | |
C57BL/KsJ-, Lepdb/+ (db/+) | Mice | 10 mg/kg | During pregnancy | Glucose metabolism, insulin tolerance↑, glucose-6-phosphatase↓ | [2] | |
C57BL/6 | Mice | 0.20% | 18 gestation days | p-Akt, miR-23a-3p, p-PI3K, adiponectin, leptin↑ | [31] | |
Female ob/ob mice, female C57BL/6J mice | Mice | 3.75 mg/kg | 20 d | Plasma insulin and T levels↓, IL-6, TNF-α levels reverted back to normalcy | [44] | |
Female Sprague-Dawley rats | Rats | 100 mg/kg | 10 gestation days | p38, JNK, ERK, and RAR phosphorylation return normal | [25] | |
Female Sprague-Dawley rats | Rats | 240 mg/kg | 12 gestation days | TC, TG, LDL-C, leptin, resistin, TNF-α, and IL-6↓, HDL-C, adiponectin↑ | [41] | |
Female Sprague-Dawley rats | Rats | 147 mg/kg | 3-wk lactation period | Blood glucose levels↓, insulin secretion↑ | Male offspring obese↓, hepatic steatosis, insulin resistance, glucose intolerance and dysregulated gluconeogenesis↓ | [39] |
Pregnant rats | Rats | 100 mg/kg | 10 gestation days | Glucose and lipid profile↑ | Embryo weight↑, rump length, somite number↓ | [54] |
Pregnant rats | Rats | 100 mg/kg | 4 d (gestation days 8th to 12th) | - | Teratogenic effects↓, scavenging enzymes catalase, superoxide dismutase, glutathione peroxidase↓ | [56] |
Hypoxia-induced rat model of IUGR | Rats | 4 g/kg | 9 wk | Intra-abdominal fat deposition, accumulation of TG and ceramides↓, plasma lipid profile↑ | [62] | |
Chicken embryo | Chicken | 1 nM/egg | 5 embryonic days | Death rate, developmental damage, vessel injury↓ | [61] | |
Between the 24th and 28th weeks’ gestation | Human | 80 mg/day | 60 d | Total cholesterol, HDL, LDL, triglycerides, and glucose blood levels↓ | [40] | |
Mature adipocytes | Human | 100 μM | 45 min to 4 h | Isoprenaline stimulation↑, impaired insulin antilipolytic action | [43] | |
Placenta, omental and subcutaneous adipose tissue and skeletal muscle | Human | 200 μM | 20 h | IL-6, IL-1α, IL-1β, pro-inflammatory chemokines IL-8, MCP-1↓ | [46] | |
Heparinized placentae | Human | 50 and 100 μM, 5 mL boluses at 30 min intervals | 150 min | CX3CL1, TNF-α↓ | [37] |
- Citation: Ma HZ, Chen Y, Guo HH, Wang J, Xin XL, Li YC, Liu YF. Effect of resveratrol in gestational diabetes mellitus and its complications. World J Diabetes 2023; 14(6): 808-819
- URL: https://www.wjgnet.com/1948-9358/full/v14/i6/808.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i6.808